Primary liver cancer
Conditions
Interventions
experimental group:Chemoembolization with Drug-Eluting Beads
Sponsors
Fujian Medical University Union Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) The diagnosis is in accordance with the standard of diagnosis and treatment for primary liver cancer (2019 edition) and the initial treatment of patients with CNLC staging (Stage I A-III B) , in which stage I A-II B must be inoperable or inoperable or unwilling to undergo the above treatment and require TACE treatment and signature; (2) Liver function Child-Pugh grade A or B; (3) Eastern Cooperative Oncology Group Performance Status (ECOG PS)0-2; (4) Tumor occupied less than 70% of liver volume; (5) Sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Primary malignant tumor with other sites; (2) other operations, ablation or other anti-tumor drugs were performed in the same period; (3) coexisting immune diseases; (4) severe and irreversibly impaired coagulation; (5) the main trunk of portal vein was completely embolized by carcinoma, and less collateral vessels were formed; (6) patients with active hepatitis or severe infection who can not be treated simultaneously; (7) extensive distant metastasis with an estimated survival period of less than 3 months; (8) cachexia or multiple organ failure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| T cell subsets; | — |
Secondary
| Measure | Time frame |
|---|---|
| Objective Response Rate;Progression Free Survival;Overall Survival; | — |
Countries
China
Contacts
Public ContactXie Hang
Fujian Medical University Union Hospital
Outcome results
None listed